drugset / Trial / NCT02812771

Safety and Pharmacokinetics of Efinaconazole Topical Solution in Subjects With Mild to Severe Onychomycosis

NCT02812771

Phase 4 Completed 62 enrolled Bausch Health Americas, Inc.
NaSingle-groupOpen-labelTreatment

Summary

Safety and Pharmacokinetics (PK) of a once daily topical application of efinaconazole in the treatment of pediatric subjects with mild to severe onychomycosis of the toenails.

Timeline

Start
2016-08-04
Primary completion
2019-01-14
Completion
2019-01-14

Drugs

EvaluationDrugModalityDoseRoute
Subject Efinaconazole Small molecule Topical